IGM Biosciences, Inc. Proceeds from Stock Plans
IGM Biosciences, Inc. reported Proceeds from Stock Plans of $4.00 thousand for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockPlans · last filed 2025-07-31
- IGM Biosciences, Inc. proceeds from stock plans for the quarter ending 2024-12-31 was $331.00K, a 15.78% decline year-over-year.
- IGM Biosciences, Inc. proceeds from stock plans for the quarter ending 2024-09-30 was $0.00.
- IGM Biosciences, Inc. proceeds from stock plans for the quarter ending 2023-12-31 was $393.00K, a 5.98% decline year-over-year.
- IGM Biosciences, Inc. proceeds from stock plans for the quarter ending 2023-09-30 was $0.00.
- IGM Biosciences, Inc. proceeds from stock plans for fiscal 2024 was $913.00K, a 34.03% decline from fiscal 2023.
- IGM Biosciences, Inc. proceeds from stock plans for fiscal 2023 was $1.38M, a 54.64% increase from fiscal 2022.
- IGM Biosciences, Inc. proceeds from stock plans for fiscal 2022 was $895.00K, a 1.10% decline from fiscal 2021.
- IGM Biosciences, Inc. proceeds from stock plans for fiscal 2021 was $905.00K, a 32.50% increase from fiscal 2020.
| Period end | Proceeds from Stock Plans 3 month | Proceeds from Stock Plans 6 month | Proceeds from Stock Plans 9 month | Proceeds from Stock Plans 12 month |
|---|---|---|---|---|
| 2025-06-30 | $4.00K 10-Q · filed 2025-07-31 | |||
| 2024-12-31 | $331.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $331.00K derived: sum of 2 quarters · filed 2025-03-06 | $913.00K 10-K · filed 2025-03-06 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $582.00K 10-Q · filed 2024-11-08 | ||
| 2024-06-30 | $582.00K 10-Q · filed 2025-07-31 | |||
| 2023-12-31 | $393.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $393.00K derived: sum of 2 quarters · filed 2025-03-06 | $1.38M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $991.00K 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | $991.00K 10-Q · filed 2024-08-14 | |||
| 2022-12-31 | $418.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $418.00K derived: sum of 2 quarters · filed 2025-03-06 | $895.00K 10-K · filed 2025-03-06 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $477.00K 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $477.00K 10-Q · filed 2023-08-03 | |||
| 2021-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $500.00K derived: sum of 2 quarters · filed 2024-03-07 | $905.00K 10-K · filed 2024-03-07 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $405.00K 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $405.00K 10-Q · filed 2022-08-08 | |||
| 2020-12-31 | $366.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $366.00K derived: sum of 2 quarters · filed 2023-03-30 | $683.00K 10-K · filed 2023-03-30 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $317.00K 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $317.00K 10-Q · filed 2021-08-09 |